Salicylcurcumin
|
- $81 - $632
- Product name: Salicylcurcumin
- CAS: 1236545-54-2
- MF: C19H16O4
- MW: 308.33
- EINECS:
- MDL Number:
- Synonyms:Salicylcurcumin;(1E,4Z,6E)-5-hydroxy-1,7-bis(2-hydroxyphenyl)hepta-1,4,6-trien-3-one;1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(2-hydroxyphenyl)-, (1E,4Z,6E)-
4 prices
Selected condition：
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- ManufacturerAK Scientific
- Product number4083CS
- Product description1,7-Bis(2-hydroxyphenyl)-5-hydroxy-1,4,6-heptatriene-3-one
- Packaging5mg
- Price$495
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number11878
- Product descriptionSalicylcurcumin ≥95%
- Packaging1mg
- Price$81
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number11878
- Product descriptionSalicylcurcumin ≥95%
- Packaging5mg
- Price$356
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number11878
- Product descriptionSalicylcurcumin ≥95%
- Packaging10mg
- Price$632
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 4083CS | 1,7-Bis(2-hydroxyphenyl)-5-hydroxy-1,4,6-heptatriene-3-one | 5mg | $495 | 2021-12-16 | Buy |
| Cayman Chemical | 11878 | Salicylcurcumin ≥95% | 1mg | $81 | 2024-03-01 | Buy |
| Cayman Chemical | 11878 | Salicylcurcumin ≥95% | 5mg | $356 | 2024-03-01 | Buy |
| Cayman Chemical | 11878 | Salicylcurcumin ≥95% | 10mg | $632 | 2024-03-01 | Buy |
Properties
Boiling point :556.1±50.0 °C(Predicted)
Density :1.319±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml
form :A crystalline solid
pka :8.34±0.60(Predicted)
Density :1.319±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml
form :A crystalline solid
pka :8.34±0.60(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|